@otherperspective - (the sites immune system is auto immuning)
Mesoblast was told by the FDA to re submit and they could defer the adult trial until after approval.
Glad you found the coloring for you helpful. I sort of expected you might not answer the question - but good for you. This time I've added blue because its possible some might think the FDA actually said MSB "could defer the adult trial until after approval"
Mesoblast was told by the FDA to re submit and they could defer the adult trial until after approval.
What is your source for the blue bit that you included in your sentence as that is what I have now posted back to you as your own words twice now?
Any MSB ASX source for the FDA saying that (the blue bit in an MSB announcement) ?
Because I've read a certain Cameron Stewart who quoted Sivliu previously and then referred again more recently to his own article using a hyperlink that stressed it was Silviu speaking where Silviu had gotten if the artiial and quotes are true very expansive. And these statement although opinions of mine are substantiate able.
And I honestly think that if those statements were made in an ASX announcement they'd have had a lot more positive impact if they are actually true statements of what Silviu said that the FDA said know.
But full disclosure by me - I don't believe the FDA talks like Cameron England quotes Silviu as talking - I think Cameron and your self are amplifiers. And I think your are amplifying now.
But a source for you blue colored part or a clarification by you might clear things up.
BTW> I am not shorting - and never have shorted MSB. I don't care if shorters slaughter pumpers using my arguments - the arguments are either true or false on their own substance - I care about the medicines.
To be clear its your reply to the blue bit that was the yellow bit that you said that I want your source for.
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-247
-
- There are more pages in this discussion • 138 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.44 |
Change
0.000(0.00%) |
Mkt cap ! $1.644B |
Open | High | Low | Value | Volume |
$1.44 | $1.46 | $1.43 | $422.3K | 292.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 6667 | $1.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.45 | 4833 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 6432 | 1.440 |
5 | 15982 | 1.435 |
10 | 102037 | 1.430 |
10 | 79683 | 1.425 |
7 | 56205 | 1.420 |
Price($) | Vol. | No. |
---|---|---|
1.445 | 2748 | 1 |
1.450 | 23232 | 9 |
1.455 | 34491 | 6 |
1.460 | 68203 | 7 |
1.465 | 3879 | 2 |
Last trade - 10.33am 15/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
Previous Video
Next Video
SPONSORED BY The Market Online